HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cutting edge: CD8+ recent thymic emigrants exhibit increased responses to low-affinity ligands and improved access to peripheral sites of inflammation.

Abstract
To explore the TCR sensitivity of recent thymic emigrants (RTEs), we triggered T cells with altered peptide ligands (APLs). Upon peptide stimulation in vitro, RTEs exhibited increased TCR signal transduction, and following infection in vivo with APL-expressing bacteria, CD8 RTEs expanded to a greater extent in response to low-affinity Ags than did their mature T cell counterparts. RTEs skewed to short-lived effector cells in response to all APLs but also were characterized by diminished cytokine production. RTEs responding to infection expressed increased levels of VLA-4, with consequent improved entry into inflamed tissue and pathogen clearance. These positive outcomes were offset by the capacity of RTEs to elicit autoimmunity. Overall, salient features of CD8 RTE biology should inform strategies to improve neonatal vaccination and therapies for cancer and HIV, because RTEs make up a large proportion of the T cells in lymphodepleted environments.
AuthorsAmy M Berkley, Pamela J Fink
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 193 Issue 7 Pg. 3262-6 (Oct 01 2014) ISSN: 1550-6606 [Electronic] United States
PMID25172492 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
CopyrightCopyright © 2014 by The American Association of Immunologists, Inc.
Chemical References
  • Antigens
  • Integrin alpha4beta1
  • Receptors, Antigen, T-Cell
Topics
  • Animals
  • Antigens (genetics, immunology)
  • CD8-Positive T-Lymphocytes (immunology, pathology)
  • Cell Movement (genetics, immunology)
  • Inflammation (genetics, immunology, pathology)
  • Integrin alpha4beta1 (genetics, immunology)
  • Mice
  • Mice, Transgenic
  • Receptors, Antigen, T-Cell (genetics, immunology)
  • Signal Transduction (genetics, immunology)
  • Thymus Gland (immunology, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: